The ASPREE study will recruit 19,000 healthy participants, both males and females,
aged 65 years or older.
Participants will be recruited in the United States through clinical trial centers throughout the US. To find an ASPREE location near you, please
click here.
ASPREE will also be conducted in Australia, where approximately 12,500 participants will be recruited through their general practice in Melbourne, regional Victoria, Tasmania and the Australian Capital Territory.
People are eligible to take part in this study if they are:
- aged 65 years or over
- a healthy individual
- willing and able to provide informed consent
People cannot take part if they:
- have blood vessel disease.
- have a serious illness.
- are allergic to aspirin or cannot take it.
- have had or are at risk of serious bleeding.
- are taking other 'blood thinning' medication.
- have seriously impaired mental or physical function.
To find eligible participants in Australia, researchers will recruit General Practitioners
(GPs) to join the study as co-investigators.
Those interested in participating in ASPREE will complete a brief phone screen to determine if they are eligible and answer some basic questions about their medical history and the medications they take. Anyone who is eligible and wishes to continue will then attend a clinic visit where blood work and mental and physical tests will be performed. A one month supply of “run-in” medication will then be given to those who qualify for enrollment. At the end of the screening phase, people willing to continue will be randomized (randomly assigned like the flip of a coin) to take either aspirin or placebo (a dummy pill) for an average of five years.
How to join?
To see if you may qualify for ASPREE, please contact an ASPREE location near you. For a complete list of ASPREE locations, please click here.